RGC
ELV icon

Roberts, Glore & Co’s Elevance Health ELV Stock Holding History

Roberts, Glore & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$727K Sell
1,879
-180
-9% -$66.8K 0.18% 114
2026
Q1 		$603K Buy
2,059
+10
+0.5% +$3.29K 0.17% 120
2025
Q4 		$718K Sell
2,049
-146
-7% -$49.3K 0.19% 109
2025
Q3 		$709K Sell
2,195
-614
-22% -$191K 0.19% 105
2025
Q2 		$1.09M Buy
2,809
+484
+21% +$195K 0.32% 79
2025
Q1 		$1.01M Buy
2,325
+113
+5% +$45.4K 0.31% 78
2024
Q4 		$816K Buy
2,212
+1,540
+229% +$644K 0.24% 90
2024
Q3 		$349K Sell
672
-11
-2% -$5.88K 0.1% 157
2024
Q2 		$370K Hold
683
– – 0.11% 146
2024
Q1 		$354K Buy
683
+144
+27% +$71.6K 0.11% 148
2023
Q4 		$254K Sell
539
-2
-0.4% -$925 0.08% 179
2023
Q3 		$236K Hold
541
– – 0.08% 177
2023
Q2 		$240K Buy
541
+4
+0.7% +$1.84K 0.08% 180
2023
Q1 		$247K Hold
537
– – 0.08% 173
2022
Q4 		$275K Sell
537
-36
-6% -$18.3K 0.1% 151
2022
Q3 		$260K Hold
573
– – 0.09% 156
2022
Q2 		$277K Hold
573
– – 0.09% 154
2022
Q1 		$281K Sell
573
-2
-0.3% -$914 0.08% 167
2021
Q4 		$267K Hold
575
– – 0.07% 168
2021
Q3 		$214K Sell
575
-20
-3% -$7.6K 0.07% 182
2021
Q2 		$227K Hold
595
– – 0.07% 179
2021
Q1 		$214K Sell
595
-102
-15% -$32.8K 0.07% 182
2020
Q4 		$223K Buy
+697
New +$214K 0.07% 170
2016
Q1 		– Sell
-1,468
Closed -$205K – 141
2015
Q4 		$205K Sell
1,468
-112
-7% -$15.4K 0.16% 130
2015
Q3 		$221K Hold
1,580
– – 0.17% 120
2015
Q2 		$259K Sell
1,580
-50
-3% -$7.99K 0.18% 116
2015
Q1 		$252K Hold
1,630
– – 0.17% 118
2014
Q4 		$205K Buy
+1,630
New +$201K 0.14% 134

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Roberts, Glore & Co's ELV Position: Q2 2026 in Review

Roberts, Glore & Co reduced its Elevance Health (ELV) stake by 8.7% in Q2 2026, selling an estimated $66.8K and leaving 1,879 shares worth $727K. The position accounts for 0.18% of the portfolio, ranked #114.

Roberts, Glore & Co first reported a position in ELV in Q4 2014 and has held it in 28 quarters since. The position peaked at $1.09M in Q2 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Roberts, Glore & Co held 1,879 shares of Elevance Health worth $727K as of Q2 2026.
  • Roberts, Glore & Co sold 180 Elevance Health shares in Q2 2026, an estimated $66.8K.
  • Elevance Health made up 0.18% of Roberts, Glore & Co's portfolio in Q2 2026, its #114 holding.
  • Roberts, Glore & Co first reported a position in Elevance Health in Q4 2014 and has held it in 28 quarters since.
  • Roberts, Glore & Co's Elevance Health position peaked at $1.09M in Q2 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Roberts, Glore & Co's 13F filing for Q2 2026, filed 11 Aug 2026.